168. Components of Intensive Treatment (Continued)

Treating Tobacco Use and Dependence: 2008 Update

Text version of slide presentation.

Text description is below image

Medication Every smoker should be offered medications endorsed in this Guideline, except where contraindicated or for specific populations for which there is insufficient evidence of effectiveness (i.e., pregnant women, smokeless tobacco users, light smokers and adolescents; see Table 3.2 for clinical Guidelines and Tables 3.3-3.11 for specific instructions and precautions). The clinician should explain how medications increase smoking cessation success and reduce withdrawal symptoms. The first-line medications include: bupropion SR, nicotine gum, nicotine inhaler, nicotine lozenge, nicotine nasal spray, nicotine patch, and varenicline. Certain combinations of cessation medications are also effective. Combining counseling and medication increases abstinence rates.
Population Intensive intervention programs may be used with all tobacco users willing to participate in such efforts.

Previous Slide        Contents         Next Slide 

Page last reviewed October 2014
Page originally created September 2012
Internet Citation: 168. Components of Intensive Treatment (Continued). Content last reviewed October 2014. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/presentations/2008update-full/slide168.html